The cardiac sodium channel Na v 1.5 plays a key role in excitability and conduction. The 3 last residues of Na v 1.5 (Ser-Ile-Val) constitute a PDZ-domain binding motif that interacts with the syntrophin-dystrophin complex. As dystrophin is absent at the intercalated discs, Na v 1.5 could potentially interact with other, yet unknown, proteins at this site.
T he cardiac sodium channel Na v 1.5 initiates the cardiac action potential, thus playing a key role in cardiac excitability and impulse propagation. The physiological importance of this channel is illustrated by numerous cardiac pathologies caused by hundreds of mutations identified in SCN5A, the gene encoding Na v 1.5. 1 The Na v 1.5 channel is composed of one 220-kDa ␣-subunit that constitutes a functional channel, and 30-kDa ␤-subunits. In addition to these accessory ␤-subunits, several proteins have been shown to regulate and interact with Na v 1.5. 1, 2 In most cases, the physiological relevance of these interactions is poorly under-stood, mainly because of a lack of appropriate animal models. Many of the interacting proteins bind to the C terminus of Na v 1.5, where several protein-protein interaction motifs are located. 1, 2 We have shown that the ubiquitin-protein ligase Nedd4-2 binds the PY motif of Na v 1.5 and reduces the sodium current (I Na ) in HEK293 cells by promoting its internalization. 3 We have also demonstrated that Na v 1.5 associates with the dystrophin-syntrophin multiprotein complex (DMC) in cardiac cells. 4 In dystrophin-deficient mice (mdx 5cv ), I Na and total Na v 1.5 protein expression are reduced. The association between Na v 1.5 and dystrophin occurs via the syntrophin family of adaptor proteins, 3 of which are expressed in the heart. 4 The PDZ domain of syntrophin binds to the last 3 C-terminal residues of Na v 1.5 (Ser-Ile-Val, SIV), a PDZ-domain binding motif that mediates the interaction with dystrophin and other proteins of the DMC. 2 Interestingly, dystrophin has been shown to be absent from the intercalated discs of human 6 and rat 7 cardiac cells, suggesting that the Na v 1.5 channels present at these locations may interact with other regulatory or anchoring proteins.
Proteins of the membrane associated guanylate kinase (MAGUK) family are characterized by numerous proteinprotein interaction domains, including PDZ domains. 8 They are involved in the function and localization of many ion channels in neurons and epithelial cells, mostly at cell to cell junctions, but little is known about their function in the heart. 9 SAP97 (synapse associated protein) and ZO-1 (zonula occludens) are the main MAGUK proteins expressed in cardiomyocytes. 9 PSD95 (postsynaptic density) is also expressed in the human heart, but not in the mouse heart. 9,10 SAP97 regulates the targeting and localization of cardiac potassium channels, such as Kir2.x 11 and K v 1.5 in myocytes. 10 El-Haou et al 12 recently demonstrated that SAP97 interacts with K v 4.2 and K v 4.3 channels via their PDZ-domain binding motif. They showed that suppression of SAP97 expression in rat myocytes decreases the K v 4.x-mediated current, whereas its overexpression increases it. In neurons, PSD95, which is closely related to SAP97, plays a role in clustering and anchoring ion channels to the postsynaptic plasma membrane. 13 Because PSD95 is also present in the human heart and SAP97 has been shown to interact with potassium channels in cardiac cells, we hypothesized that one of these cardiac MAGUK proteins may also associate with Na v 1.5.
In this study, we provide evidence for the coexistence of at least 2 pools of Na v 1.5 channels in cardiomyocytes, one located at the lateral membrane with the DMC, and the other localizing with SAP97 at the intercalated discs. In sections and isolated cardiomyocytes of dystrophin-deficient mice, we observed a drastic reduction of the pool of Na v 1.5 channels located at the lateral membrane. This loss could underlie the significant reduction of conduction velocity observed in these dystrophin-deficient hearts using optical measurements. Finally, we also found that the surface expression of Na v 1.5 in HEK293 cells is regulated by its interaction with SAP97.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Cell Preparation, Transfection, and Infection
HEK293 and Sk-Hep cells were cultured as previously described. 3
Silencing and Lentiviruses
HEK293 cells stably expressing Na v 1.5 were transfected using Lipofectamine (Invitrogen) as detailed in the Online Data Supplement. HEK293 cells were infected with VSV-G pseudo-typed lentiviruses. 14 Adult rat cardiomyocytes were transfected with silencing plasmids, as previously published. 12
Transfection
For patch-clamp experiments, HEK293 cells were transiently transfected using calcium phosphate with the different constructs mentioned in the text. Details are given in the Online Data Supplement.
Protein Extraction, Pull-Down, and Western Blot
These procedures were performed as previously reported with HEK293 and Sk-Hep cells. 4 See Online Data Supplement for other tissues.
Biotinylation Assay
Transfected HEK293 cells were biotinylated as detailed in the Online Data Supplement. Biotinylated proteins were then analyzed by Western blot.
Immunohistochemistry of Rat and Mouse Ventricular Sections
Immunostainings were performed on heart cryosections as described in the Online Data Supplement.
Isolation and Immunocytochemistry of Mouse Ventricular Myocytes
See the Online Data Supplement for a detailed description.
Electrophysiology
Patch-clamp recordings were carried out in the whole-cell configuration at room temperature using solutions previously described. 4 See the Online Data Supplement for details.
Conduction Velocity Measurements on Isolated Mouse Hearts
Optical measurements of conduction velocity (CV) were performed on isolated wild-type and dystrophin-deficient mdx mouse hearts as described in detail in the Online Data Supplement.
Statistical Analysis
Data are represented as mean valuesϮSEM, unless otherwise indicated.
Results

Na v 1.5 Is Localized With Dystrophin and Syntrophins Only at the Lateral Membrane
We recently demonstrated that Na v 1.5 associates with the DMC in cardiac cells. 4 We also observed that sodium current (I Na ) and Na v 1.5 protein expression is reduced in dystrophindeficient (mdx 5cv ) mice compared to wild type (WT). 4 To further study the importance of this multiprotein complex, we analyzed the distribution of Na v 1.5 channels, as well as that of dystrophin and syntrophin in rat ventricular sections ( Figure 1A and 1B) . Immunostaining experiments showed that Na v 1.5 is distributed along the entire membrane of rat cardiomyocytes ( Figure 1A and 1B, left). In contrast, we 
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observed that Na v 1.5 and dystrophin are in the same membrane compartment exclusively at the lateral membrane ( Figure 1A , right), and not at the intercalated discs, where dystrophin is absent (white arrowheads, Figure 1A , middle and right). Similar results were obtained using an antibody that recognized all syntrophin isoforms ( Figure 1B ). Syntrophins are similarly in close proximity to Na v 1.5 exclusively at the lateral membrane ( Figure 1B , white arrowheads). In mouse ventricular sections, similar findings were obtained with Na v 1.5, dystrophin, and syntrophin (Online Figure I) .
These results suggest that Na v 1.5 could be part of at least 2 different protein complexes: with dystrophin at the lateral membrane and with another partner at the intercalated discs.
Na v 1.5 Is Decreased at the Lateral Membranes of Dystrophin-Deficient Myocytes
Immunohistochemistry experiments were performed using WT and mdx 5cv mouse ventricular sections ( Figure 2A ). A strong reduction of Na v 1.5 staining was observed at the lateral membrane of mdx 5cv mouse cardiomyocytes ( Figure  2A , bottom) compared to WT mice (Figure 2A , top). Similarly, immunocytochemistry performed on isolated mouse cardiomyocytes confirmed that Na v 1.5 is distributed along the entire cell membrane in these cells, and that lateral Na v 1.5 staining in dystrophin-deficient cardiomyocytes is strongly reduced when compared to WT ( Figure 2B ). These results suggest that the decrease in Na v 1.5 protein and I Na previously seen in dystrophin-deficient mice 4 is the consequence of a loss of Na v 1.5 channels at the lateral membrane of cardiomyocytes.
Impulse Propagation Is Significantly Slowed in Hearts of mdx Mice
Reduced I Na and Na v 1.5 protein in dystrophin-deficient hearts may contribute to the previously observed prolongation of the QRS complex duration observed in ECG recordings of mdx 5cv mice. 4 To investigate whether conduction velocity (CV) is reduced in dystrophin-deficient hearts, we performed optical measurements in isolated Langendorff-perfused WT and mdx hearts stained with the fluorescent voltage-reporter dye Di-4-ANNEPS. Conduction spread of the paced (cycle length 100 ms) left ventricle free wall was recorded following equilibration and confirmation of physiological spontaneous heart rates (500 to 600/min, by volumetric ECG). Maximal CV occurred in the same direction in WT and mdx hearts along the longitudinal (apico-aortal) heart axis. Isochrone maps from WT hearts showed regular anisotropic conduction spread around a point-like pacing stimulus originating from the free LV wall center ( Figure 3A , left). Accordingly, CV analysis by ellipsis fitting confirmed longitudinal and transversal velocities consistent with rapid ellipsoid conduction spread and physiological anisotropy ( Figure 3A , right) (see online supplemental methods for detailed description). However, conduction spread of mdx hearts resulted in tighter isochrone maps indicating conduction slowing in all directions ( Figure 3B , left). In agreement with this observation ellipsis fitting analysis confirmed slowing of conduction spread in the transversal axis resulting in reduced conduction velocities ( Figure 3B , right). Figure 3C shows that in contrast to WT hearts, dystrophin-deficient hearts showed on average a reduction in transversal CV by 22.2% from 0.45Ϯ0.08 m/sec to 0.35Ϯ0.07 m/sec (WT nϭ5, mdx nϭ8; PϽ0.05) and in longitudinal CV by 12.7% from 0.71Ϯ0.14 m/sec to 0.62Ϯ0.11 m/sec (WT nϭ5, mdx nϭ8; PϭNS). Additionally, CV has been analyzed by a second method using averaged CV vectors along the apparent longitudinal and transversal heart axis (see online supplementary methods for detailed description). Figure 3D confirms that in contrast to WT hearts, dystrophin-deficient hearts showed a longitudinal 28.4% reduction in CV (WT nϭ5, mdx nϭ8; PϽ0.005). In addition, transversal CV was significantly reduced by 22.4% in mdx compared to WT hearts (WT nϭ5, mdx nϭ8; PϽ0.05; Figure 3D ). The combined reduction of transversal and longitudinal CVs resulted in a 7.3% reduction in the anisotropic ratio (WT nϭ5, mdx nϭ8; PϭNS; Figure  3D ) when analyzed by averaged CV vectors and by 10.7% when analyzed by the ellipsis fitting method (WT nϭ5, mdx nϭ8; PϭNS; Figure 3C ). Thus, under quasi-physiological conditions mimicking the resting mouse heart rate of 600/min the mdx left ventricle showed significantly slower excitation spread both in the longitudinal and transversal directions, confirming the slowed impulse propagation suggested by the widening of QRS complex. As distribution and expression of the main ventricular connexin, Cx43, is unaltered in mdx hearts (see Online Figure II and elsewhere 4 ), this may suggest a selective role of Na v 1.5 channels located at the lateral membrane for impulse propagation in cardiac muscle.
The Carboxyl Terminus of Na v 1.5 Interacts With SAP97
To identify proteins that could specifically interact with the fractions of Na v 1.5 at the intercalated discs, we studied proteins of the MAGUK family. We performed pull-down experiments using GST-fusion proteins comprising the last 66 amino acids of the C terminus (C-ter) of Na v 1.5, as well as fusion proteins lacking the 3 last SIV residues (⌬SIV, Figure  4A ). Western blot experiments performed using an anti-PSD95 family antibody, known to recognize several cardiac MAGUKs ( Figure 4B , Online Figure III ), revealed that Na v 1.5 C-ter WT precipitated proteins containing PDZ domains (2 bands at Ϸ140 kDa, the molecular weight of SAP97) from mouse ventricles and human atrium. This interaction is dependent on the PDZ-domain binding motif of Na v 1.5, as no protein was observed with the truncated construct. Similar results were obtained using a SAP97 specific antibody ( Figure 4C , Online Figure III) . The similarity between these 2 results ( Figure 4B and 4C) suggests that SAP97 is the predominant MAGUK interacting with Na v 1.5. To assess if this interaction was specific for SAP97, we tested a specific PSD95 antibody ( Figure 4D ). No interaction was seen with either fusion protein (Na v 1.5 C-ter WT or ⌬SIV). We also verified whether Na v 1.5 C terminus could interact with ZO-1, a cardiac MAGUK protein known to interact with connexins. We generated a fusion protein containing the last amino acids of connexin-45 (Cx45) ( Figure 4A ), which has previously been shown to bind ZO-1. 15 Pull-down experiments performed using SK-Hep cell lysates, which express ZO-1 endogenously, confirmed that Cx45 C-ter precipitated ZO-1, but that Na v 1.5 C-ter ( Figure  4E ) did not. Combined, these results support a specific interaction between the PDZ-domain binding motif of Na v 1.5 and SAP97 in mouse ventricles and human atria.
Localization of SAP97, Na v 1.5, Cx43, and Syntrophin in Rat Cardiomyocytes
To analyze the distribution of Na v 1.5 and SAP97 in native cardiac tissue, we performed immunostainings using Na v 1.5, SAP97 and Cx43 antibodies on rat heart sections. As present- A, Na v 1.5 (green) in WT (top) and mdx 5cv (bottom) ventricular sections. Note the loss of lateral membrane Na v 1.5 staining in the mdx 5cv sections; intercalated disc staining remains almost unaffected. B, Cardiomyocytes labeled for Na v 1.5 (green, left) and dystrophin (red, right). Note the absence of dystrophin staining at the intercalated discs in WT cardiomyocytes (cf, insets with magnifications). Mdx cardiomyocytes were identified by the negative dystrophin staining (bottom, right). In isolated mdx cardiomyocytes, Na v 1.5 staining was similarly markedly reduced at the lateral membrane. ed in Figure 5A , SAP97 is predominantly expressed at the intercalated discs ( Figure 5A, middle) where Na v 1.5 is also observed (white arrowheads, Figure 5A right). We also performed coimmunostainings of SAP97 and Cx43, showing that both proteins are located at the intercalated discs (white arrowheads, Figure 5B , right).
Silencing of SAP97 in HEK293 Cells, Cardiomyocytes, and Na v 1.5 Channels Lacking the SIV-Domain Reduces I Na
The results presented in Figure 4 indicate that Na v 1.5 and SAP97 interact via their SIV-motif and PDZ domain, respectively. Electrophysiological studies were performed to characterize the role of this interaction. First, patch-clamp experiments using HEK293 cells transiently transfected with Na v 1.5 and SAP97 were carried out. Unexpectedly, expression of SAP97 did not modify I Na (not shown). This result could be an indication that endogenous SAP97 is expressed at a saturating level in HEK293 cells. We subsequently reduced the expression of SAP97 using short hairpin (sh)RNA. When HEK293 cells expressing Na v 1.5 (HEK293-Na v 1.5) were transfected with SAP97 silencing plasmids, I Na was reduced by 55Ϯ4% ( Figure 6B ). However, the transfection technique was not efficient enough to silence SAP97 expression in the majority of the cells. Therefore, we developed a lentivirusbased strategy to deliver shRNA. Western-blots performed with HEK293 cells infected with shRNA-containing lentiviruses revealed that SAP97 expression was drastically reduced (Ϫ83%, Figure 6A ) when compared to nonsilenced cells infected with scrambled shRNA. In HEK293-Na v 1.5 cells silenced with lentiviruses, we observed a reduction of I Na that was comparable to the results obtained when using the silencing plasmid (not shown). Next, we studied the consequence of silencing SAP97 on endogenous I Na in rat atrial myocytes maintained in short term culture. This procedure has been previously shown to efficiently suppress endogenous cardiac SAP97. 12 After 3 to 4 days of culture, current recordings at -20 mV using green-fluorescent atrial myocytes (Ϸ20% of the cells) revealed a much smaller I Na in myocytes transfected with shSAP97 than those with scrambled shRNA (Ϫ66Ϯ8%, Figure 6C ). SAP97-silenced or scrambled HEK293 cells were then transiently transfected with Na v 1.5 WT or ⌬SIV. The current generated by Na v 1.5 ⌬SIV channels was reduced by 57Ϯ9% compared to WT channels in control cells expressing the scrambled shRNA ( Figure 6D ). In silenced cells (shSAP97), WT and ⌬SIV I Na were comparable (49Ϯ11% and 57Ϯ7% of control values, respectively, Figure  6D ). Voltage dependence of activation and inactivation was not significantly different between the four conditions (see Online Figure V ). Because ␤1 subunits are known to associate with Nav1.5, 16 we performed similar experiments using HEK293 cells transfected with Na v 1.5 WT or ⌬SIV and ␤1. The results were similar whether the ␤1 subunit was present or not (Online Figure VIA) , without affecting the voltage dependence of activation and inactivation (Online Figure  VIB) . We finally investigated whether the reduced I Na could be rescued by another protein bearing a PDZ binding domain. As shown in Online Figure VII , overexpression of ␣1syntrophin (previously shown to interact with Na v 1.5 4 ) in silenced cells did not increase I Na .
Silencing of SAP97 in Cultured Rat Atrial Myocytes Reorganizes Na v 1.5 Expression
We also investigated whether silencing of SAP97 (Ad shSAP97) alters the organization of Na v 1.5 in cardiomyocytes, using a model of cultured atrial myocytes at confluence stage when cells reestablish highly organized cell-cell contacts as previously shown. 17 Immunostainings on short-term cultured rat atrial myocytes indicate that the total expression of Na v 1.5 channels in myocytes transduced with shSAP97 is reduced when compared to cells overexpressing SAP97 (Ad SAP97), and that the localization of the channels at the plasma membrane is reorganized (Online Figure IVA) . Costainings of Na v 1.5 and syntrophin on rat cardiomyocytes confirm that these 2 proteins are both localized at the cell surface but not at cell-cell contacts where syntrophin is absent 
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Two Pools of Na v 1.5 Channels (Online Figure IV, B, top) . In SAP97 silenced myocytes, syntrophin expression remains unchanged at the level of non-cell-to-cell contacts (Online Figure IVB, bottom) .
Expression of Na v 1.5 Channels Lacking the SIV-Domain Is Reduced at the Cell Surface of HEK293 Cells and SAP97-Silenced Cells
Electrophysiological data indicate that I Na is dependent on the presence of SAP97 as well as on the SIV motif of Na v 1.5. We examined whether the reduced current amplitude was attributable to decreased expression of the channel at the cell surface. Surface biotinylation assays performed on HEK293 cells that had been transiently transfected with Na v 1.5 WT or ⌬SIV ( Figure 7A and 7B) revealed that cell membrane expression of truncated channels was reduced by 27Ϯ3% compared to WT channels, without affecting total Na v 1.5 protein expression. Similar experiments using scrambleinfected HEK293 cells yielded comparable results (35Ϯ6% reduction; Figure 7C and 7D) . When SAP97-silenced HEK293 cells were transfected with WT or ⌬SIV channels, the number of channels expressed at the cell membrane was further reduced (56Ϯ5% and 56Ϯ6%; Figure 7C and 7D) .
These results suggest that the decreased I Na measured in SAP97-silenced cells or those with truncated channels may be attributable to reduced cell surface expression of Na v 1.5, supporting the idea that SAP97 regulates cell membrane density of Na v 1.5. Data presented in Online Figure VIII show that this regulation is independent of the ubiquitin-protein ligase Nedd4-2, which we have previously shown to regulate the number of Na v 1.5 channels at the cell surface by interacting with a PY-motif found at the C terminus of the channel. 3
Discussion
The major findings of the present study are: (1) Na v 1.5 is part of at least 2 distinct multiprotein complexes in cardiomyocytes, one localized at the lateral membrane with dystrophin and syntrophin proteins, and the other involving the MAGUK protein SAP97 at the intercalated discs; (2) specific regulation of lateral membrane localization and density of Na v 1.5 is dependent on dystrophin expression, the absence of which may underlie conduction slowing observed in dystrophindeficient hearts; and (3) the absence of the SIV motif of Na v 1.5 or depletion of SAP97 results in reduced channel expression at the cell surface, and a subsequent decrease of I Na in HEK293 cells and adult cardiac myocytes.
Distribution of Na v 1.5 Channels in Cardiomyocytes
Studies investigating the localization of Na v 1.5 at the cell membrane of cardiac cells have revealed conflicting results. Although many articles have described Na v 1.5 stainings at the intercalated discs and lateral membrane of rat, 18, 19 mouse, 20 dog, 21 and human 22 cardiomyocytes, other studies have shown almost exclusive expression of the channel at the intercalated discs. [23] [24] [25] These discrepancies may be attributable to the alternative use of either heart sections or isolated myocytes, where a reorganization of proteins at the plasma membrane can occur. In a recent study, 26 macropatch recordings of the 2 subcellular domains were performed, and it was concluded that the Na v 1.5-mediated current is almost nonexistent at the lateral membrane. The expression, or lack thereof, of Na v 1.5 channels at the lateral membranes likely has functional consequences on impulse propagation, as suggested by modeling studies. 25 In the present work, we demonstrate that Na v 1.5 channels are present all along the plasma membrane of both rat and mouse cardiomyocytes. This finding is supported by the reduction of lateral Na v 1.5 expression in dystrophin-deficient myocytes, with no signif-icant alteration in the expression at the intercalated discs. This observation is consistent with our previous study, 4 in which we observed a Ϸ50% decrease of total Na v 1.5 protein expression in the absence of dystrophin, with a concomitant I Na reduction. Taken together, these observations strongly support the notion that a significant fraction of functional Na v 1.5 channels are located outside of the intercalated discs. These lateral membrane channels are likely to play a role in conduction, because their reduction alters ventricular conduction, which is reflected in a widening of the QRS complex in ECG recordings from mdx 5cv mice where the hearts are otherwise free from structural remodeling. 4 Confirming this concept, we show here for the first time, using noninvasive optical measurements of conduction velocity from the left ventricle free wall, and by 2 different analysis methods, that impulse propagation is significantly slowed in the transversal direction in dystrophin-deficient hearts that have reduced expression Na v 1.5 at the lateral membrane. These findings are in line with those of Baba and coworkers, 21 who showed that dog cardiomyocytes isolated from peri-infarcted zones displayed reduced I Na density, associated with specific loss of the Na v 1.5 staining at the lateral membranes only. As the Na v 1.5 staining remained unchanged at intercalated discs, the reduction of I Na was proposed to be the cause of altered impulse propagation in the diseased tissue. 21 These observa- tions are also in agreement with those of a recent study 27 reporting reduced excitability, slowed conduction velocity, and altered Na v 1.5 expression in hearts of mdx mice. However, these investigators partly attributed these results to a reorganization of Cx43. Similarly to Sanford and coworkers, we could not confirm this finding in the present study, and found no remodeling of Cx43. 28
Interaction Between Na v 1.5 and SAP97 at Intercalated Discs
The carboxyl terminus of Na v 1.5 has several protein-protein interaction domains that associate with numerous partners to regulate channel activity. 2 As aforementioned, we have reported that the last 3 residues of Na v 1.5 (SIV) interacts with the DMC, as well as with the protein tyrosine phosphatase PTPH1. 29 Other groups have reported that ion channels bearing a PDZ-domain binding motif interact with members of the MAGUK family in various tissues. 8 Several potassium channels of the K ir and K v families display PDZ-domain binding motifs that interact with the MAGUK proteins PSD95 or SAP97. 8, 12 Our pull-down experiments strongly support the existence of an interaction between Na v 1.5 and SAP97 in cardiac tissue via the Na v 1.5 SIV motif. These results are supported by a recent study, 30 that suggests that Na v 1.5 binds the first PDZ domain of SAP97. In our study, we also describe a close localization of SAP97 and Na v 1.5 at intercalated discs. Immunostainings confirm data from Godreau et al 9 who found an enrichment of SAP97 at this subcellular site. These results suggest that SAP97 is involved in targeting or anchoring of Na v 1.5 channels to the intercalated discs of cardiomyocytes. Furthermore, SAP97 expression is unaltered in hearts of mdx mice (see Online Figure  IX) , indicating that the pool of Na v 1.5 channels regulated at their PDZ domain-binding motif in the intercalated discs could be independent of the one complexed to syntrophin and DMC at lateral membranes of cardiomyocytes.
Physiological Relevance of the Two Regulating Mechanisms
In addition to the DMC, ankyrin-G has also been shown to interact with and regulate the trafficking of Na v 1.5 at the cell membrane of cardiomyocytes. 31, 32 Ankyrin-G is primarily expressed at the intercalated discs, with another population at T-tubules; it is therefore unlikely that it is responsible for the specific targeting of Na v 1.5 to the 2 compartments observed in our study. Whether the roles of syntrophin-dystrophin and ankyrin-G in trafficking, targeting, and anchoring of Na v 1.5 to the lateral membrane are complementary or partly redundant remains to be elucidated. It may be speculated that ankyrin-G is involved in forward trafficking and correct targeting of the channel, and that PDZ-domain proteins anchor it in specific membrane compartments. The exact molecular mechanisms underlying the loss of Na v 1.5 expression at the lateral membrane in the absence of dystrophin remains still unclear. Cheng and coworkers 33 recently described several mutations in the gene encoding ␣1-syntrophin in patients with sudden infant death syndrome. Despite these results, clearly demonstrating the importance of ␣1syntrophin in cardiomyocytes function, our data suggest that this protein complex is restricted to the lateral membrane. Sato and coworkers 34 recently demonstrated that I Na is regulated by the protein plakophilin-2, which is enriched at the intercalated discs. 35 Because plakophilin-2 does not contain a PDZ domain, this suggests that Na v 1.5 could be differentially regulated by multiple proteins at the intercalated discs including SAP97 and plakophilin-2, similarly to the lateral membrane where it interacts with the DMC and ankyrin-G, within complexes that may or may not be distinct (Figure 8 ). Deciphering the specific and distinct roles of the different proteins in trafficking and/or anchoring of cardiac ion channels including Na v 1.5 to different cellular compartments will be the goal of future experiments.
Limitations of the Study
This study demonstrates the presence of at least 2 different populations of Na v 1.5 channels in cardiac cells. However the use of the mdx mouse as a disease model does not allow final conclusions about the physiological function of the 2 different Na v 1.5 compartments. The optical mapping data indicate conduction slowing in all directions, and because the exact fiber orientation of the given cardiac substrate is not known, we assume that fiber orientation is similar in WT and mdx hearts at young ages in agreement with previous studies. In addition, our data do not show significant reduction of Na v 1.5 expression at the intercalated disc in mdx hearts based on confocal immunofluorescence data. Nevertheless, potential changes of the mdx membrane ultrastructure at this complex site could underlie alterations in intercalated disc excitability that could not be established specifically here because of resolution limitations of confocal light microscopy. Furthermore, subtle, as yet unrecognized intercellular histological changes in mdx hearts could also contribute to the conduction slowing observed in optical mapping experiments and are subject to the same microscopy diffraction limitations. On the other hand, the present data suggests that SAP97 is predominantly localized in intercalated discs, and that SAP97 protein expression is not different in mdx mouse hearts. However, because immunostaining of SAP97 in mouse heart failed to produce specific staining despite repeated attempts with different antibodies and tissue fixations, possible reorganization of SAP97 cannot be excluded. Finally, potential upregulation or remodeling of connexins other than Cx43 was not addressed in this study.
Conclusions
The present study provides evidence that a fraction of Na v 1.5 channels is regulated by the DMC at the lateral myocyte membrane, and a different pool interacts with SAP97 at the intercalated discs of cardiomyocytes. Although the functional relevance of these distinct localizations of the main cardiac sodium channel has yet to be clarified, this study establishes that lateral sodium channels have a role in cardiac impulse propagation. Generation of a cardiac-specific SAP97 knock-out mouse models will likely elucidate the specific roles of this protein in cardiac function. Finally, similar to previous examples of proteins interacting with Na v 1.5, 2 genetic variants of SAP97 may be linked to pathological cardiac phenotypes.
